Influence of the Eliminated Ligand Structure on the Reduction Rate of the Cobalt(III) Complexes
- 作者: Nikovskii I.A.1, Spiridonov K.A.1,2, Dan′shina A.A.1,3, Khakina E.A.1, Nelyubina Y.V.1
-
隶属关系:
- Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
- Moscow State University
- Moscow Institute of Physics and Technology (National Research University)
- 期: 卷 50, 编号 4 (2024)
- 页面: 251-260
- 栏目: Articles
- URL: https://rjonco.com/0132-344X/article/view/667605
- DOI: https://doi.org/10.31857/S0132344X24040039
- EDN: https://elibrary.ru/NPVTSR
- ID: 667605
如何引用文章
详细
The reduction of the heteroleptic cobalt(III) complexes with bipyridine ligands of different structures of the model drug molecule is studied by in situ NMR spectroscopy. The nature of the ligand eliminated during reduction is shown to exert a substantial effect on the reduction rate, which indicates that an optimum amount of cobalt should be chosen for the redox-activated delivery of a certain drug.
全文:

作者简介
I. Nikovskii
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: khakina90@ineos.ac.ru
俄罗斯联邦, Moscow
K. Spiridonov
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences; Moscow State University
Email: khakina90@ineos.ac.ru
俄罗斯联邦, Moscow; Moscow
A. Dan′shina
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences; Moscow Institute of Physics and Technology (National Research University)
Email: khakina90@ineos.ac.ru
俄罗斯联邦, Moscow; Dolgoprudnyi
E. Khakina
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
编辑信件的主要联系方式.
Email: khakina90@ineos.ac.ru
俄罗斯联邦, Moscow
Yu. Nelyubina
Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences
Email: khakina90@ineos.ac.ru
俄罗斯联邦, Moscow
参考
- Jungwirth, U., Kowol, C.R., Keppler, B.K., et al., Antioxid. Redox. Signaling, 2011, vol. 15, p. 1085.
- Brown, J.M. and Wilson, W.R., Nat. Rev. Cancer, 2004, vol. 4, p. 437.
- Denny, W.A., Cancer Invest., 2004, vol. 22, p. 604.
- Graf, N. and Lippard, S.J., Adv. Drug. Deliv. Rev., 2012, vol. 64, p. 993.
- Ware, D.C., Siim, B.G., Robinson, K.G., et al., Inorg. Chem., 1991, vol. 30, p. 3750.
- Craig, P.R., Brothers, P.J., Clark, G.R., et al., Dalton Trans., 2004, vol. 4, p. 611.
- Failes, T.W., Cullinane, C., Diakos, C.I., et al., Chem.-Eur. J., 2007, vol. 13, p. 2974.
- Karnthaler-Benbakka, M.S.C., Groza, M.S.D., Kryeziu, M.K., et al., Angew. Chem., Int. Ed. Engl., 2014, vol. 53, p. 12930.
- Palmeira-Mello, M.V., Caballero, A.B., Ribeiro, J.M., et al., J. Inorg. Biochem., 2020, vol. 211, p. 111211.
- Souza, I.S.A., Santana, S.S., Gomez, J.G., et al., Dalton Trans., 2020, vol. 49, p. 16425.
- Khakina, E.A., Nikovskii, I.A., Babakina, D.A., et al., Russ. J. Coord. Chem., 2023, vol. 49, p. 24. https://doi.org/10.1134/S1070328422700105
- Cioncoloni, G., Senn, H.M., Sproules, S., et al., Dalton Trans., 2016, vol. 45, p. 15575.
- Vlcek, A.A., Inorg. Chem., 1967, vol. 6, p. 1425.
- Ma, D.-L., Wu, C., Cheng, S.-S., et al., Int. J. Mol. Sci., 2019, vol. 20, p. 341.
- Sheldrick, G.M., Acta Crystallogr., Sect. A: Found. Crystallogr., 2008, vol. 64, p. 112.
- Dolomanov, O.V., Bourhis, L.J., Gildea, R.J., et al., J. Appl. Crystallogr., 2009, vol. 42, p. 339.
- Stamatatos, T.C., Bell, A., Cooper, P., et al., Inorg. Chem. Commun., 2005, vol. 8, p. 533.
- Alvarez, S., Chem. Rev., 2015, vol. 115, p. 13447.
补充文件
